1-855-378-42281-855-378-4228
One of the out-patient treatment alternatives for people in West Somerset who are struggling with opioid dependence and addiction is called opioid maintenance therapy. Some clinics and doctors are authorized to give certain medications to opioid addicted people, many that are opioid-based themselves and are addictive. In low amounts the client does not experience high feelings and also does not have intense cravings and is not experiencing opioid withdrawal. Methadone is the first drug administered for this sole purpose, but there are alternative options currently to pick from.
Methadone is an opiate and can be taken at an outpatient medical center certified to administer the med, that is taken on a daily basis as a pill or liquid. The cost of the drug is approximately under $200 per month. Buprenorphine is also an opioid-based drug, and is in pill form often taken one day on, one day off. But different from Methadone that is only be administered in highly structured clinics, Buprenorphine can be and is prescribed and dispensed in doctor's offices. The cost monthly of buprenorphine is about three hundred dollars per month for the generic of the drug. There is also a type of buprenorphine that contains naloxone, which is a med that blocks the effects of opioids. A person taking this formulation, AKA Suboxone, would find it harder to feel high from opioids if they relapsed while taking the drug. It is also taken every day, and costs around $450 /month. Naltrexone is another medication used in opioid maintenance therapy, but unlike the other medications mentioned here it's an opioid blocker and isn't an opioid. A person has the choice to take this drug as a monthly shot, and that is called Vivitrol. As an opioid blocker, the drug prevents a person from experience high feelings from opioids, and therefore lowers the risk associated with relapse. This daily injection costs in the range of $1000 to $1200 per month.
For All Drug and Alcohol Rehabilitation Centers In West Somerset, Click Here.
